|
SFRS4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.409590E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.041800E-02 |
| Normal-vs-Stage2 |
3.068600E-01 |
| Normal-vs-Stage3 |
8.360800E-01 |
| Normal-vs-Stage4 |
8.094600E-01 |
| Stage1-vs-Stage2 |
5.858400E-01 |
| Stage1-vs-Stage3 |
6.563900E-02 |
| Stage1-vs-Stage4 |
2.130800E-01 |
| Stage2-vs-Stage3 |
2.817600E-01 |
| Stage2-vs-Stage4 |
3.140000E-01 |
| Stage3-vs-Stage4 |
9.549200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.205690E-02 |
| Normal-vs-AfricanAmerican |
1.805610E-01 |
| Normal-vs-Asian |
6.635600E-01 |
| Caucasian-vs-AfricanAmerican |
2.931200E-01 |
| Caucasian-vs-Asian |
5.776400E-01 |
| AfricanAmerican-vs-Asian |
7.691600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.338260E-02 |
| Normal-vs-Female |
9.654000E-02 |
| Male-vs-Female |
6.719000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.078800E-01 |
| Normal-vs-Extreme_Weight |
3.771700E-02 |
| Normal-vs-Obese |
9.901600E-02 |
| Normal-vs-Extreme_Obese |
4.639400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.041000E-01 |
| Normal_Weight-vs-Obese |
8.566400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.587000E-01 |
| Extreme_Weight-vs-Obese |
6.995200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.278600E-01 |
| Obese-vs-Extreme_Obese |
7.590200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.663960E-01 |
| Normal-vs-Age(41-60Yrs) |
7.800200E-03 |
| Normal-vs-Age(61-80Yrs) |
4.035600E-02 |
| Normal-vs-Age(81-100Yrs) |
8.941800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.241200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.563000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.937400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.879200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.285050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.381000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.26399999999627E-05 |
| Normal-VS-Type2 PRCC |
2.743500E-02 |
| Normal-VS-KIRP CIMP |
8.690000E-01 |
| Normal-VS-Unclassified PRCC |
1.347820E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.4432899320127E-15 |
| Type1 PRCC-VS-KIRP CIMP |
2.807600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.488300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.068000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.200010E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.454800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.704000E-01 |
| Normal-vs-N1 |
7.237000E-01 |
| Normal-vs-N2 |
8.835600E-01 |
| N0-vs-N1 |
8.062000E-01 |
| N0-vs-N2 |
8.595600E-01 |
| N1-vs-N2 |
9.612600E-01 |
|
|
